Results from WIN-TAVI real world-registry, outcomes of women after TAVI
Women might make up 50% of patients undergoing TAVI today for treatment of symptomatic severe aortic stenosis, but is this really the optimal treatment strategy? Join A. Chieffo as she walks us through WIN-TAVI, the first “real-world”, all-female, international registry of over 1,000 patients from 19 centres in Europe and the United States.
Learn about the design of this pioneering project and whether sex-specific characteristics have been seen to have an impact on clinical outcomes after TAVI. What further research needs to be done today? These points and more can be found here…